Advertisement

The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome

  • Ilske Oschlies
  • Rebecca L. King
  • Snjezana Dotlic
  • Santiago Montes-Moreno
  • Maurilio Ponzoni
  • Alexandra Traverse-Glehen
  • Maria Calaminici
  • Judith A. Ferry
  • German Ott
  • John R GoodladEmail author
Review and Perspectives
Part of the following topical collections:
  1. Extranodal Lymphoproliferations: Organotypic Diseases and Diagnostic Challenges

Abstract

The major aim of Session 1 of the 2018 European Association of Hematopathology/Society for Hematopathology Workshop was to collect examples of cutaneous lymphomas, excluding mycosis fungoides/Sezary syndrome, as defined in the current WHO classification of tumours of the haemetopoietic and lymphoid tissues. Overall 42 cases were submitted. These were considered in four main categories: primary cutaneous B cell lymphomas (12 cases), primary cutaneous T cell lymphomas/lymphoproliferations with CD8+/cytotoxic phenotype (12 cases), primary cutaneous CD30-positive lymphoproliferative disorders (15 cases) and primary cutaneous T cell lymphomas/leukaemias with CD4+ phenotype (4 cases). Using these cases as examples, we were able to present the full spectrum of cutaneous lymphoproliferations (excluding mycosis fungoides/Sezary syndrome), including examples of rare, provisional and new entities as listed in the 2017 update of the WHO classification. The findings are summarized in this report with emphasis on differential diagnostic considerations and the importance of clinico-pathological correlation for final subtyping. In presenting these findings we hope to raise awareness of this enigmatic group of neoplasms and to further our understanding of these rare disease entities.

Keywords

Cutaneous lymphomas Primary cutaneous B cell lymphoma Primary cutaneous T cell lymphomas Primary cutaneous CD30-positive lymphoproliferative disorder Primary cutaneous CD8-positive lymphomas 

Notes

Acknowledgements

The authors thank all workshop participants for their case submissions and for use of images in this review.

Author contributions

All authors conceived and designed the review; all authors participated into the collection, discussion and the final diagnostic work-up of the submitted cases. All authors wrote, edited and reviewed the manuscript; all authors gave their final approval for publication. I.O and J.G. take full responsibility to the work as a whole including the reported data from individual workshop cases.

Compliance with ethical standards

All authors declare strict adherence to compliance with ethical standards.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390CrossRefGoogle Scholar
  2. 2.
    Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES (2019) The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood.  https://doi.org/10.1182/blood-2018-11-881268 CrossRefGoogle Scholar
  3. 3.
    Charli-Joseph Y, Cerroni L, LeBoit PE (2015) Cutaneous spindle-cell B-cell lymphomas: most are neoplasms of follicular center cell origin. Am J Surg Pathol 39(6):737–743CrossRefGoogle Scholar
  4. 4.
    Oschlies I, Kohler CW, Szczepanowski M, Koch K, Gontarewicz A, Metze D, Hillen U, Richter J, Spang R, Klapper W (2017) Spindle-cell variants of primary cutaneous follicle center B-cell lymphomas are germinal center B-cell lymphomas by gene expression profiling using a formalin-fixed paraffin-embedded specimen. The Journal of investigative dermatology 137(11):2450–2453.  https://doi.org/10.1016/j.jid.2017.06.016 CrossRefPubMedGoogle Scholar
  5. 5.
    Pham-Ledard A, Cowppli-Bony A, Doussau A, Prochazkova-Carlotti M, Laharanne E, Jouary T, Belaud-Rotureau MA, Vergier B, Merlio JP, Beylot-Barry M (2015) Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions. Am J Clin Pathol 143(3):362–373CrossRefGoogle Scholar
  6. 6.
    Gango A, Batai B, Varga M, Kapczar D, Papp G, Marschalko M, Kuroli E, Schneider T, Csomor J, Matolcsy A, Bodor C, Szepesi A (2018) Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein. Virchows Arch 473(4):453–462.  https://doi.org/10.1007/s00428-018-2384-3 CrossRefPubMedGoogle Scholar
  7. 7.
    Verdanet E, Dereure O, Rene C, Tempier A, Benammar-Hafidi A, Gallo M, Frouin E, Durand L, Gazagne I, Costes-Martineau V, Cacheux V, Szablewski V (2017) Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas. Histopathology 71(4):648–660.  https://doi.org/10.1111/his.13279 CrossRefPubMedGoogle Scholar
  8. 8.
    Walsh NM, Lano IM, Green P, Gallant C, Pasternak S, Ly TY, Requena L, Kutzner H, Chott A, Cerroni L (2017) AL amyloidoma of the skin/subcutis: cutaneous amyloidosis, plasma cell dyscrasia or a manifestation of primary cutaneous marginal zone lymphoma? Am J Surg Pathol 41(8):1069–1076.  https://doi.org/10.1097/pas.0000000000000861 CrossRefPubMedGoogle Scholar
  9. 9.
    Kamarashev J, Schaerer L, Burg G, Schmid MH, Muller B, Kempf W (2001) Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders. J Cutan Pathol 28(9):448–452CrossRefGoogle Scholar
  10. 10.
    van Maldegem F, van Dijk R, Wormhoudt TA, Kluin PM, Willemze R, Cerroni L, van Noesel CJ, Bende RJ (2008) The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment. Blood 112(8):3355–3361.  https://doi.org/10.1182/blood-2008-01-132415 CrossRefPubMedGoogle Scholar
  11. 11.
    Geyer JT, Ferry JA, Longtine JA, Flotte TJ, Harris NL, Zukerberg LR (2010) Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background. Am J Clin Pathol 133(1):59–69.  https://doi.org/10.1309/ajcpw64ffbttpkfn CrossRefPubMedGoogle Scholar
  12. 12.
    Wobser M, Maurus K, Roth S, Appenzeller S, Weyandt G, Goebeler M, Rosenwald A, Geissinger E (2017) Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal-zone lymphoma with a nonclass-switched immunoglobulin M immunophenotype. Br J Dermatol 177(2):564–566.  https://doi.org/10.1111/bjd.15183 CrossRefPubMedGoogle Scholar
  13. 13.
    Maurus K, Appenzeller S, Roth S, Kuper J, Rost S, Meierjohann S, Arampatzi P, Goebeler M, Rosenwald A, Geissinger E, Wobser M (2018) Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma. The Journal of investigative dermatology 138(7):1573–1581.  https://doi.org/10.1016/j.jid.2018.02.015 CrossRefPubMedGoogle Scholar
  14. 14.
    Wehkamp U, Pott C, Unterhalt M, Koch K, Weichenthal M, Klapper W, Oschlies I (2015) Skin involvement of mantle cell lymphoma may mimic primary cutaneous diffuse large B-cell lymphoma, leg type. Am J Surg Pathol 39(8):1093–1101CrossRefGoogle Scholar
  15. 15.
    Menguy S, Prochazkova-Carlotti M, Beylot-Barry M, Saltel F, Vergier B, Merlio JP, Pham-Ledard A (2018) PD-L1 and PD-L2 are differentially expressed by macrophages or tumor cells in primary cutaneous diffuse large B-cell lymphoma, leg type. Am J Surg Pathol 42(3):326–334.  https://doi.org/10.1097/pas.0000000000000983 CrossRefPubMedGoogle Scholar
  16. 16.
    Schrader AMR, Jansen PM, Vermeer MH, Kleiverda JK, Vermaat JSP, Willemze R (2018) High incidence and clinical significance of MYC rearrangements in primary cutaneous diffuse large B-cell lymphoma, leg type. Am J Surg Pathol 42(11):1488–1494.  https://doi.org/10.1097/pas.0000000000001132 CrossRefPubMedGoogle Scholar
  17. 17.
    Woroniecka R, Rymkiewicz G, Grygalewicz B, Blachnio K, Rygier J, Jarmuz-Szymczak M, Ratajczak B, Pienkowska-Grela B (2015) Cytogenetic and flow cytometry evaluation of Richter syndrome reveals MYC, CDKN2A, IGH alterations with loss of CD52, CD62L and increase of CD71 antigen expression as the most frequent recurrent abnormalities. Am J Clin Pathol 143(1):25–35.  https://doi.org/10.1309/ajcpatrqwanw2o3n CrossRefPubMedGoogle Scholar
  18. 18.
    Mareschal S, Pham-Ledard A, Viailly PJ, Dubois S, Bertrand P, Maingonnat C, Fontanilles M, Bohers E, Ruminy P, Tournier I, Courville P, Lenormand B, Duval AB, Andrieu E, Verneuil L, Vergier B, Tilly H, Joly P, Frebourg T, Beylot-Barry M, Merlio JP, Jardin F (2017) Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing. The Journal of investigative dermatology 137(9):1984–1994.  https://doi.org/10.1016/j.jid.2017.04.010 CrossRefPubMedGoogle Scholar
  19. 19.
    Bosisio F, Boi S, Caputo V, Chiarelli C, Oliver F, Ricci R, Cerroni L (2015) Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: a conceptual and practical dilemma. Am J Surg Pathol 39(2):206–211.  https://doi.org/10.1097/pas.0000000000000307 CrossRefPubMedGoogle Scholar
  20. 20.
    LeBlanc RE, Tavallaee M, Kim YH, Kim J (2016) Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis. Am J Surg Pathol 40(6):745–754.  https://doi.org/10.1097/pas.0000000000000596 CrossRefPubMedGoogle Scholar
  21. 21.
    Goodlad JR (2015) Indolent CD8-positive lymphoid proliferation of acral sites: identifying the sheep in wolf’s clothing. Br J Dermatol 172(6):1480–1481.  https://doi.org/10.1111/bjd.13765 CrossRefPubMedGoogle Scholar
  22. 22.
    Guitart J, Martinez-Escala ME, Subtil A, Duvic M, Pulitzer MP, Olsen EA, Kim E, Rook AH, Samimi SS, Wood GS, Girardi M, Junkins-Hopkins J, Ivan DS, Selim MA, Sable KA, Virmani P, Pincus LB, Tetzlaff MT, Kim J, Kim YH (2017) Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas. Mod Pathol 30(5):761–772.  https://doi.org/10.1038/modpathol.2016.240 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Pulitzer M, Geller S, Kumar E, Frosina D, Moskowitz A, Horwitz S, Myskowski P, Kheterpal M, Chan A, Dogan A, Jungbluth A (2018) T-cell receptor-delta expression and gammadelta+ T-cell infiltrates in primary cutaneous gammadelta T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders. Histopathology 73(4):653–662.  https://doi.org/10.1111/his.13671 CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Willemze R, Pauli M, Kadin ME (2017) Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Swerdlow S, Campo E, Harris N et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edn. IARC, Lyon, France, pp 395–396Google Scholar
  25. 25.
    Goodlad JR (2014) The many faces of lymphomatoid papulosis. Diagnostic Histopathology 20:263–270CrossRefGoogle Scholar
  26. 26.
    El Shabrawi-Caelen L, Kerl H, Cerroni L (2004) Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 140(4):441–447.  https://doi.org/10.1001/archderm.140.4.441 CrossRefPubMedGoogle Scholar
  27. 27.
    Macaulay WL (1989) Lymphomatoid papulosis update. A historical perspective. Arch Dermatol 125(10):1387–1389CrossRefGoogle Scholar
  28. 28.
    Kempf W, Kazakov DV, Paredes BE, Laeng HR, Palmedo G, Kutzner H (2013) Primary cutaneous anaplastic large cell lymphoma with angioinvasive features and cytotoxic phenotype: a rare lymphoma variant within the spectrum of CD30+ lymphoproliferative disorders. Dermatology (Basel, Switzerland) 227(4):346–352.  https://doi.org/10.1159/000355479 CrossRefGoogle Scholar
  29. 29.
    Massone C, El-Shabrawi-Caelen L, Kerl H, Cerroni L (2008) The morphologic spectrum of primary cutaneous anaplastic large T-cell lymphoma: a histopathologic study on 66 biopsy specimens from 47 patients with report of rare variants. J Cutan Pathol 35(1):46–53.  https://doi.org/10.1111/j.1600-0560.2007.00778.x CrossRefPubMedGoogle Scholar
  30. 30.
    Mann KP, Hall B, Kamino H, Borowitz MJ, Ratech H (1995) Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma. Am J Surg Pathol 19(4):407–416CrossRefGoogle Scholar
  31. 31.
    Burg G, Kempf W, Kazakov DV, Dummer R, Frosch PJ, Lange-Ionescu S, Nishikawa T, Kadin ME (2003) Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol 148(3):580–586CrossRefGoogle Scholar
  32. 32.
    Kinney MC, Higgins RA, Medina EA (2011) Anaplastic large cell lymphoma: twenty-five years of discovery. Arch Pathol Lab Med 135(1):19–43.  https://doi.org/10.1043/2010-0507-rar.1 CrossRefPubMedGoogle Scholar
  33. 33.
    Ferrara G, Ena L, Cota C, Cerroni L (2015) Intralymphatic spread is a common finding in cutaneous CD30+ lymphoproliferative disorders. Am J Surg Pathol 39(11):1511–1517.  https://doi.org/10.1097/pas.0000000000000474 CrossRefPubMedGoogle Scholar
  34. 34.
    Gratzinger D, Million L, Kim YH (2015) Occult dermal lymphatic involvement is frequent in primary cutaneous anaplastic large cell lymphoma. Am J Dermatopathol 37(10):767–770.  https://doi.org/10.1097/dad.0000000000000377 CrossRefPubMedGoogle Scholar
  35. 35.
    Onaindia A, Montes-Moreno S, Rodriguez-Pinilla SM, Batlle A, Gonzalez de Villambrosia S, Rodriguez AM, Alegre V, Bermudez GM, Gonzalez-Vela C, Piris MA (2015) Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features. Histopathology 66(6):846–855.  https://doi.org/10.1111/his.12529 CrossRefPubMedGoogle Scholar
  36. 36.
    Kummer JA, Vermeer MH, Dukers D, Meijer CJ, Willemze R (1997) Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype. The Journal of investigative dermatology 109(5):636–640.  https://doi.org/10.1111/1523-1747.ep12337633 CrossRefPubMedGoogle Scholar
  37. 37.
    Massone C, Cerroni L (2014) Phenotypic variability in primary cutaneous anaplastic large T-cell lymphoma: a study on 35 patients. Am J Dermatopathol 36(2):153–157.  https://doi.org/10.1097/DAD.0b013e3182a5683a CrossRefPubMedGoogle Scholar
  38. 38.
    Kempf W (2006) CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol 33(Suppl 1):58–70.  https://doi.org/10.1111/j.0303-6987.2006.00548.x CrossRefPubMedGoogle Scholar
  39. 39.
    de Souza A, Camilleri MJ, Wada DA, Appert DL, Gibson LE, el-Azhary RA (2009) Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients. J Am Acad Dermatol 61(6):993–1000.  https://doi.org/10.1016/j.jaad.2009.05.014 CrossRefPubMedGoogle Scholar
  40. 40.
    de Souza A, el-Azhary RA, Camilleri MJ, Wada DA, Appert DL, Gibson LE (2012) In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients. J Am Acad Dermatol 66(6):928–937.  https://doi.org/10.1016/j.jaad.2011.07.012 CrossRefPubMedGoogle Scholar
  41. 41.
    Kempf W, Kazakov DV, Scharer L, Rutten A, Mentzel T, Paredes BE, Palmedo G, Panizzon RG, Kutzner H (2013) Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas. Am J Surg Pathol 37(1):1–13.  https://doi.org/10.1097/PAS.0b013e3182648596 CrossRefPubMedGoogle Scholar
  42. 42.
    Saggini A, Gulia A, Argenyi Z, Fink-Puches R, Lissia A, Magana M, Requena L, Simonitsch I, Cerroni L (2010) A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases. Am J Surg Pathol 34(8):1168–1175.  https://doi.org/10.1097/PAS.0b013e3181e75356 CrossRefPubMedGoogle Scholar
  43. 43.
    Karai LJ, Kadin ME, Hsi ED, Sluzevich JC, Ketterling RP, Knudson RA, Feldman AL (2013) Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis. Am J Surg Pathol 37(8):1173–1181.  https://doi.org/10.1097/PAS.0b013e318282d01e CrossRefPubMedGoogle Scholar
  44. 44.
    Wada DA, Law ME, Hsi ED, Dicaudo DJ, Ma L, Lim MS, Souza A, Comfere NI, Weenig RH, Macon WR, Erickson LA, Ozsan N, Ansell SM, Dogan A, Feldman AL (2011) Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies. Mod Pathol 24(4):596–605.  https://doi.org/10.1038/modpathol.2010.225 CrossRefPubMedGoogle Scholar
  45. 45.
    Feldman AL, Law M, Remstein ED, Macon WR, Erickson LA, Grogg KL, Kurtin PJ, Dogan A (2009) Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia 23(3):574–580.  https://doi.org/10.1038/leu.2008.320 CrossRefPubMedGoogle Scholar
  46. 46.
    Pham-Ledard A, Prochazkova-Carlotti M, Laharanne E, Vergier B, Jouary T, Beylot-Barry M, Merlio JP (2010) IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases. J Invest Dermatol 130(3):816–825.  https://doi.org/10.1038/jid.2009.314 CrossRefPubMedGoogle Scholar
  47. 47.
    Feldman AL, Dogan A, Smith DI, Law ME, Ansell SM, Johnson SH, Porcher JC, Ozsan N, Wieben ED, Eckloff BW, Vasmatzis G (2011) Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood 117(3):915–919.  https://doi.org/10.1182/blood-2010-08-303305 CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL (2014) ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood 124(9):1473–1480.  https://doi.org/10.1182/blood-2014-04-571091 CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Bekkenk MW, Geelen FA, van Voorst Vader PC, Heule F, Geerts ML, van Vloten WA, Meijer CJ, Willemze R (2000) Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95(12):3653–3661CrossRefGoogle Scholar
  50. 50.
    Laharanne E, Oumouhou N, Bonnet F, Carlotti M, Gentil C, Chevret E, Jouary T, Longy M, Vergier B, Beylot-Barry M, Merlio JP (2010) Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. J Invest Dermatol 130(6):1707–1718.  https://doi.org/10.1038/jid.2010.8 CrossRefPubMedGoogle Scholar
  51. 51.
    Sanchez NP, Pittelkow MR, Muller SA, Banks PM, Winkelmann RK (1983) The clinicopathologic spectrum of lymphomatoid papulosis: study of 31 cases. J Am Acad Dermatol 8(1):81–94CrossRefGoogle Scholar
  52. 52.
    Zirbel GM, Gellis SE, Kadin ME, Esterly NB (1995) Lymphomatoid papulosis in children. J Am Acad Dermatol 33(5 Pt 1):741–748CrossRefGoogle Scholar
  53. 53.
    Kunishige JH, McDonald H, Alvarez G, Johnson M, Prieto V, Duvic M (2009) Lymphomatoid papulosis and associated lymphomas: a retrospective case series of 84 patients. Clin Exp Dermatol 34(5):576–581.  https://doi.org/10.1111/j.1365-2230.2008.03024.x CrossRefPubMedGoogle Scholar
  54. 54.
    Chott A, Vonderheid EC, Olbricht S, Miao NN, Balk SP, Kadin ME (1996) The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol 106(4):696–700CrossRefGoogle Scholar
  55. 55.
    de la Garza Bravo MM, Patel KP, Loghavi S, Curry JL, Torres Cabala CA, Cason RC, Gangar P, Prieto VG, Medeiros LJ, Duvic M, Tetzlaff MT (2015) Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin. Hum Pathol 46(4):558–569.  https://doi.org/10.1016/j.humpath.2014.12.008 CrossRefPubMedGoogle Scholar
  56. 56.
    Zackheim HS, Jones C, Leboit PE, Kashani-Sabet M, McCalmont TH, Zehnder J (2003) Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality. J Am Acad Dermatol 49(4):620–623CrossRefGoogle Scholar
  57. 57.
    Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES (2012) Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma. Am J Surg Pathol 36(5):716–725.  https://doi.org/10.1097/PAS.0b013e3182487158 CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Xerri L, Adelaide J, Avenin M, Guille A, Taix S, Bonnet N, Carbuccia N, Garnier S, Mescam L, Murati A, Chaffanet M, Coso D, Bouabdallah R, Bertucci F, Birnbaum D (2019) Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution. Histopathology 74(4):654–662.  https://doi.org/10.1111/his.13783 CrossRefPubMedGoogle Scholar
  59. 59.
    Sciallis AP, Law ME, Inwards DJ, McClure RF, Macon WR, Kurtin PJ, Dogan A, Feldman AL (2012) Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol 25(7):983–992.  https://doi.org/10.1038/modpathol.2012.38 CrossRefPubMedGoogle Scholar
  60. 60.
    Wang W, Cai Y, Sheng W, Lu H, Li X (2014) The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol 117(1):96–104.  https://doi.org/10.1016/j.oooo.2013.10.002 CrossRefPubMedGoogle Scholar
  61. 61.
    Agarwal M, Shenjere P, Blewitt RW, Hall G, Sloan P, Pigadas N, Banerjee SS (2008) CD30-positive T-cell lymphoproliferative disorder of the oral mucosa—an indolent lesion: report of 4 cases. Int J Surg Pathol 16(3):286–290.  https://doi.org/10.1177/1066896907313755 CrossRefPubMedGoogle Scholar
  62. 62.
    Sciubba J, Said-Al-Naief N, Fantasia J (2000) Critical review of lymphomatoid papulosis of the oral cavity with case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90(2):195–204.  https://doi.org/10.1067/moe.2000.107054 CrossRefPubMedGoogle Scholar
  63. 63.
    Chimenti S, Fargnoli MC, Pacifico A, Peris K (2001) Mucosal involvement in a patient with lymphomatoid papulosis. J Am Acad Dermatol 44(2 Suppl):339–341CrossRefGoogle Scholar
  64. 64.
    Pujol RM, Muret MP, Bergua P, Bordes R, Alomar A (2005) Oral involvement in lymphomatoid papulosis. Report of two cases and review of the literature. Dermatology (Basel, Switzerland) 210(1):53–57.  https://doi.org/10.1159/000081485 CrossRefGoogle Scholar
  65. 65.
    Alobeid B, Pan LX, Milligan L, Budel L, Frizzera G (2004) Eosinophil-rich CD30+ lymphoproliferative disorder of the oral mucosa. A form of “traumatic eosinophilic granuloma”. Am J Clin Pathol 121(1):43–50.  https://doi.org/10.1309/jqfx-pnd6-dblf-6b9u CrossRefPubMedGoogle Scholar
  66. 66.
    Hirshberg A, Amariglio N, Akrish S, Yahalom R, Rosenbaum H, Okon E, Kaplan I (2006) Traumatic ulcerative granuloma with stromal eosinophilia: a reactive lesion of the oral mucosa. Am J Clin Pathol 126(4):522–529.  https://doi.org/10.1309/afha406gbt0n2y64 CrossRefPubMedGoogle Scholar
  67. 67.
    Segura S, Pujol RM (2008) Eosinophilic ulcer of the oral mucosa: a distinct entity or a non-specific reactive pattern? Oral Dis 14(4):287–295.  https://doi.org/10.1111/j.1601-0825.2008.01444.x CrossRefPubMedGoogle Scholar
  68. 68.
    Segura S, Romero D, Mascaro JM Jr, Colomo L, Ferrando J, Estrach T (2006) Eosinophilic ulcer of the oral mucosa: another histological simulator of CD30+ lymphoproliferative disorders. Br J Dermatol 155(2):460–463.  https://doi.org/10.1111/j.1365-2133.2006.07331.x CrossRefPubMedGoogle Scholar
  69. 69.
    Ficarra G, Prignano F, Romagnoli P (1997) Traumatic eosinophilic granuloma of the oral mucosa: a CD30+(Ki-1) lymphoproliferative disorder? Oral Oncol 33(5):375–379CrossRefGoogle Scholar
  70. 70.
    el-Mofty SK, Swanson PE, Wick MR, Miller AS (1993) Eosinophilic ulcer of the oral mucosa. Report of 38 new cases with immunohistochemical observations. Oral Surg Oral Med Oral Pathol 75(6):716–722CrossRefGoogle Scholar
  71. 71.
    Gaulard P, Berti E, Willemze R, Petrella T, Jaffe ES (2017) Primary cutaneous gamma delta t-cell lymphoma. In: Swerdlow SH, Camp E, Harris NL(eds). Who classification of tumours of haematopoietic and lymphoid tissues. World Health Organization, revised 4th edn. IARC Press, Lyon, pp 397–398Google Scholar
  72. 72.
    Krenacs D, Bakos A, Torok L, Kocsis L, Bagdi E, Krenacs L (2016) Neoplastic cells of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma lack the expression of follicular T-helper cell defining chemokine receptor CXCR5. Acta Derm Venereol 96(6):850–852.  https://doi.org/10.2340/00015555-2386 CrossRefPubMedGoogle Scholar
  73. 73.
    Rodriguez Pinilla SM, Roncador G, Rodriguez-Peralto JL, Mollejo M, Garcia JF, Montes-Moreno S, Camacho FI, Ortiz P, Limeres-Gonzalez MA, Torres A, Campo E, Navarro-Conde P, Piris MA (2009) Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 33(1):81–90.  https://doi.org/10.1097/PAS.0b013e31818e52fe CrossRefPubMedGoogle Scholar
  74. 74.
    Ally MS, Prasad Hunasehally RY, Rodriguez-Justo M, Martin B, Verdolini R, Attard N, Child F, Attygalle A, Whittaker S, Morris S, Robson A (2013) Evaluation of follicular T-helper cells in primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma and dermatitis. J Cutan Pathol 40(12):1006–1013.  https://doi.org/10.1111/cup.12234 CrossRefPubMedGoogle Scholar
  75. 75.
    Cetinozman F, Jansen PM, Willemze R (2012) Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol 36(1):109–116.  https://doi.org/10.1097/PAS.0b013e318230df87 CrossRefPubMedGoogle Scholar
  76. 76.
    Beltraminelli H, Leinweber B, Kerl H, Cerroni L (2009) Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases. Am J Dermatopathol 31(4):317–322.  https://doi.org/10.1097/DAD.0b013e31819f19bb CrossRefPubMedGoogle Scholar
  77. 77.
    Ploysangam T, Breneman DL, Mutasim DF (1998) Cutaneous pseudolymphomas. J Am Acad Dermatol 38(6 Pt 1):877–895 quiz 896-877CrossRefGoogle Scholar
  78. 78.
    Wang JY, Nguyen GH, Ruan J, Magro CM (2017) Primary cutaneous follicular helper T-cell lymphoma: a case series and review of the literature. Am J Dermatopathol 39(5):374–383.  https://doi.org/10.1097/dad.0000000000000695 CrossRefPubMedGoogle Scholar
  79. 79.
    Le Tourneau A, Audouin J, Molina T, Qubaja M, Gaulard P, Leroy JP, Molinie V, Diebold J (2010) Primary cutaneous follicular variant of peripheral T-cell lymphoma NOS. A report of two cases. Histopathology 56(4):548–551.  https://doi.org/10.1111/j.1365-2559.2010.03498.x CrossRefPubMedGoogle Scholar
  80. 80.
    Battistella M, Beylot-Barry M, Bachelez H, Rivet J, Vergier B, Bagot M (2012) Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases. Arch Dermatol 148(7):832–839.  https://doi.org/10.1001/archdermatol.2011.3269 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Ilske Oschlies
    • 1
  • Rebecca L. King
    • 2
  • Snjezana Dotlic
    • 3
  • Santiago Montes-Moreno
    • 4
  • Maurilio Ponzoni
    • 5
  • Alexandra Traverse-Glehen
    • 6
  • Maria Calaminici
    • 7
  • Judith A. Ferry
    • 8
  • German Ott
    • 9
  • John R Goodlad
    • 10
    Email author
  1. 1.Department of Pathology, Hematopathology Section and Lymph Node RegistryUniversity Hospitals Schleswig-Holstein, Christian-Albrecht-UniversityKielGermany
  2. 2.Division of HematopathologyMayo ClinicRochesterUSA
  3. 3.Department of Pathology and CytologyUniversity Hospital Centre ZagrebZagrebCroatia
  4. 4.Department of Anatomic Pathology, Translational Hematopathology LabHospital Universitario Marques de Valdecilla/IDIVALSantanderSpain
  5. 5.Ateneo Vita-Salute San Raffaele and Unit of Lymphoid MalignanciesSan Raffaele Scientific InstituteMilanItaly
  6. 6.Department of HematopathologyHospices Civils de Lyon/Université Lyon 1LyonFrance
  7. 7.Department of Cellular Pathology, SIHMDS, Barts Health NHS Trust and Centre for Haemato-OncologyBarts Cancer InstituteLondonUK
  8. 8.Department of PathologyMassachusetts General Hospital and Harvard Medical SchoolBostonUSA
  9. 9.Department of Clinical PathologyRobert-Bosch-KrankenhausStuttgartGermany
  10. 10.Department of PathologyQueen Elizabeth University HospitalGlasgowScotland

Personalised recommendations